Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)
 
 • Company Description   
MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.

Number of Employees: 506

 
 • Price / Volume Information   
Yesterday's Closing Price: $217.98 Daily Weekly Monthly
20 Day Moving Average: 31,675 shares
Shares Outstanding: 5.25 (millions)
Market Capitalization: $1,143.51 (millions)
Beta: 0.54
52 Week High: $333.42
52 Week Low: $210.11
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.81% -4.82%
12 Week -14.14% -7.21%
Year To Date -33.56% -21.31%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12100 W 6TH AVE
-
LAKEWOOD,CO 80228
USA
ph: 303-987-8000
fax: 303-987-8989
investorrelations@mesalabs.com http://www.mesalabs.com
 
 • General Corporate Information   
Officers
Gary M. Owens - Chief Executive Officer; President and Director
John J. Sullivan - Chairman of the Board of Directors
John V. Sakys - Chief Financial Officer
John B Schmieder - Director
Jennifer S. Alltoft - Director

Peer Information
Mesa Laboratories, Inc. (ABMD)
Mesa Laboratories, Inc. (DMDS)
Mesa Laboratories, Inc. (CPWY.)
Mesa Laboratories, Inc. (EQUR)
Mesa Laboratories, Inc. (ECIA)
Mesa Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 59064R109
SIC: 3823
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/07/22
Share - Related Items
Shares Outstanding: 5.25
Most Recent Split Date: (:1)
Beta: 0.54
Market Capitalization: $1,143.51 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.29%
Current Fiscal Quarter EPS Consensus Estimate: $1.08 Indicated Annual Dividend: $0.64
Current Fiscal Year EPS Consensus Estimate: $7.02 Payout Ratio: 0.14
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/25/2022 - $0.16
Next EPS Report Date: 06/07/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 31.05
Trailing 12 Months: 46.58
PEG Ratio: -
Price Ratios
Price/Book: 2.89
Price/Cash Flow: 22.60
Price / Sales: 7.00
EPS Growth
vs. Year Ago Period: -6.58%
vs. Previous Quarter: -52.35%
Sales Growth
vs. Year Ago Period: 60.06%
vs. Previous Quarter: 52.61%
ROE
03/31/22 - -
12/31/21 - 6.23
09/30/21 - 6.17
ROA
03/31/22 - -
12/31/21 - 3.92
09/30/21 - 4.08
Current Ratio
03/31/22 - -
12/31/21 - 2.59
09/30/21 - 11.13
Quick Ratio
03/31/22 - -
12/31/21 - 2.08
09/30/21 - 10.71
Operating Margin
03/31/22 - -
12/31/21 - 15.26
09/30/21 - 17.45
Net Margin
03/31/22 - -
12/31/21 - 4.64
09/30/21 - 3.56
Pre-Tax Margin
03/31/22 - -
12/31/21 - 5.21
09/30/21 - 3.59
Book Value
03/31/22 - -
12/31/21 - 75.55
09/30/21 - 76.44
Inventory Turnover
03/31/22 - -
12/31/21 - 4.38
09/30/21 - 4.40
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.58
09/30/21 - 0.42
Debt-to-Capital
03/31/22 - -
12/31/21 - 36.63
09/30/21 - 29.72
 

Powered by Zacks Investment Research ©